Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

If there is any doubt in the minds of clinical trials administrators and coordinators about the complexity of Medicare and insurer reimbursement in clinical trials, then they need look no further than what happened when the National Academy of Sciences convened a task force to address the subject five years ago: Its main proposals never were adopted.

Navigate the labyrinth of Medicare reimbursement for clinical trials